Title: Immunoproteomic Profiling of Antiviral Antibodies in New-Onset Type 1 Diabetes Using Protein Arrays
Special MTA: None
ATGCAGTTGCTCTGTGTTTTTTGCCTGGTGTTGCTATGGGAGGTGGGGGCTGCCAGCCTC
AGCGAGGTTAAGCTGCACCTGGACATAGAGGGGCATGCTTCGCATTACACCATCCCATGG
ACCGAACTGATGGCAAAGGTCCCAGGCCTTAGCCCAGAGGCGCTGTGGAGAGAGGCAAAT
GTCACCGAAGATTTGGCGTCTATGCTTAACCGCTACAAGTTAATTTACAAGACGTCTGGT
ACCCTTGGTATTGCGCTGGCCGAGCCTGTCGATATCCCTGCTGTCTCTGAAGGATCCATG
CAAGTGGATGCATCTAAGGTCCATCCCGGAGTCATTAGCGGCCTGAATTCCCCTGCCTGC
ATGCTTAGTGCCCCCCTTGAGAAGCAGCTCTTCTACTATATTGGCACCATGCTGCCCAAC
ACGCGGCCACACAGCTATGTCTTTTATCAGCTGCGCTGTCACTTGTCTTATGTGGCCCTG
TCCATCAACGGGGACAAGTTTCAGTACACGGGGGCCATGACTTCTAAATTTCTGATGGGC
ACCTACAAGCGAGTGACCGAGAAGGGAGATGAGCATGTGTTGAGCCTGGTCTTTGGCAAG
ACGAAGGACCTGCCGGATCTGAGGGGGCCTTTTAGTTACCCATCCTTAACCAGTGCCCAA
AGCGGGGACTATTCCCTGGTGATTGTTACAACCTTTGTGCATTATGCCAACTTTCACAAC
TACTTTGTACCCAACCTGAAGGATATGTTTTCCCGAGCCGTCACCATGACAGCCGCCAGC
TACGCTCGCTACGTTCTCCAGAAACTGGTCCTGCTGGAGATGAAGGGAGGCTGCCGGGAG
CCGGAACTGGACACGGAAACGCTGACTACCATGTTTGAGGTTTCTGTGGCCTTCTTTAAG
GTGGGTCATGCTGTGGGTGAGACTGGCAATGGCTGCGTGGACCTCCGCTGGTTGGCCAAG
AGCTTCTTTGAGCTGACTGTCCTGAAAGACATCATCGGCATATGTTATGGGGCCACTGTC
AAGGGCATGCAATCCTACGGGCTGGAGCGCTTGGCCGCCATGCTGATGGCCACGGTCAAG
ATGGAGGAGCTGGGTCACCTGACTACTGAGAAACAGGAGTACGCGCTGAGGTTAGCCACC
GTCGGCTACCCCAAGGCCGGGGTTTACAGTGGCCTCATTGGAGGCGCCACATCTGTGCTT
CTCTCGGCCTACAACCGCCACCCCCTTTTCCAGCCCCTGCATACCGTGATGAGAGAGACC
CTGTTTATCGGCAGCCACGTGGTGCTACGCGAGTTGCGGCTGAACGTGACTACCCAGGGG
CCCAACCTTGCCCTATACCAACTGCTGTCCACCGCCCTGTGCTCGGCCCTAGAGATTGGG
GAGGTTTTGCGGGGGCTAGCCCTGGGGACAGAGAGCGGGCTCTTCTCACCGTGCTACCTC
AGCCTACGATTTGACCTCACACGAGACAAGCTGCTGAGCATGGCCCCCCAGGAGGCAACG
CTGGACCAGGCGGCCGTTTCAAATGCTGTGGATGGGTTTCTTGGGCGGCTCTCTTTGGAG
CGAGAAGACAGGGATGCGTGGCATCTCCCCGCCTACAAATGCGTGGACAGGCTCGACAAA
GTTCTGATGATTATCCCGCTCATCAATGTGACATTCATAATCTCTAGTGACCGTGAGGTC
CGAGGCTCGGCGCTATACGAGGCCAGCACCACCTATCTCAGCAGCTCTCTCTTTCTCTCC
CCCGTTATAATGAATAAATGTTCGCAGGGTGCTGTGGCTGGGGAGCCCCGCCAGATTCCA
AAGATCCAGAATTTTACCAGGACGCAGAAATCCTGCATTTTTTGTGGCTTTGCCCTGCTC
AGTTATGATGAAAAGGAAGGCCTGGAAACTACAACCTACATCACCTCCCAGGAAGTCCAA
AACTCCATCTTGAGCTCCAACTACTTTGATTTTGACAACCTCCACGTTCACTATCTGCTG
CTGACCACCAACGGGACTGTCATGGAAATTGCGGGCCTGTATGAAGAAAGAGCACACGTT
GTTTTGGCAATAATCCTGTACTTTATTGCTTTTGCTCTGGGTATCTTTCTGGTTCACAAG
ATTGTTATGTTTTTCCTTTAG
MQLLCVFCLVLLWEVGAASLSEVKLHLDIEGHASHYTIPWTELMAKVPGLSPEALWREAN VTEDLASMLNRYKLIYKTSGTLGIALAEPVDIPAVSEGSMQVDASKVHPGVISGLNSPAC MLSAPLEKQLFYYIGTMLPNTRPHSYVFYQLRCHLSYVALSINGDKFQYTGAMTSKFLMG TYKRVTEKGDEHVLSLVFGKTKDLPDLRGPFSYPSLTSAQSGDYSLVIVTTFVHYANFHN YFVPNLKDMFSRAVTMTAASYARYVLQKLVLLEMKGGCREPELDTETLTTMFEVSVAFFK VGHAVGETGNGCVDLRWLAKSFFELTVLKDIIGICYGATVKGMQSYGLERLAAMLMATVK MEELGHLTTEKQEYALRLATVGYPKAGVYSGLIGGATSVLLSAYNRHPLFQPLHTVMRET LFIGSHVVLRELRLNVTTQGPNLALYQLLSTALCSALEIGEVLRGLALGTESGLFSPCYL SLRFDLTRDKLLSMAPQEATLDQAAVSNAVDGFLGRLSLEREDRDAWHLPAYKCVDRLDK VLMIIPLINVTFIISSDREVRGSALYEASTTYLSSSLFLSPVIMNKCSQGAVAGEPRQIP KIQNFTRTQKSCIFCGFALLSYDEKEGLETTTYITSQEVQNSILSSNYFDFDNLHVHYLL LTTNGTVMEIAGLYEERAHVVLAIILYFIAFALGIFLVHKIVMFFL*
Coding Sequence Details
Recommended Growth Condition: